Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism.
Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA.
Braadland PR, et al.
Oncotarget. 2016 Jan 12;7(2):1878-94. doi: 10.18632/oncotarget.6479.
Oncotarget. 2016.
PMID: 26646591
Free PMC article.